Trial Condition(s):

Endometriosis

Safety and efficacy of SH T00660AA in treatment of endometriosis

Bayer Identifier:

91234

ClinicalTrials.gov Identifier:

NCT00225186

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The purpose of this study is to demonstrate safety and efficacy of SH T00660AA for the treatment of endometriosis

Inclusion Criteria
- Female patients with endometriosis-associated pelvic pain
Exclusion Criteria
- Pregnant or lactating women
 - History or suspicion of hormone dependent tumor
 - Therapy resistant endometriosis or need for primary surgical treatment
 - Any other conditions which forbid the participation

Trial Summary

Enrollment Goal
168
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Visanne (Dienogest, BAY86-5258)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Heidelberg, Germany, 69115

Status
Completed
 
Locations

Investigative Site

Tuebingen, Germany, 72076

Status
Completed
 
Locations

Investigative Site

Greifswald, Germany, 17487

Status
Completed
 
Locations

Investigative Site

Weißig, Germany, 01474

Status
Completed
 
Locations

Investigative Site

Lübeck, Germany, 23538

Status
Completed
 
Locations

Investigative Site

Dippoldiswalde, Germany, 01744

Status
Completed
 
Locations

Investigative Site

Gevelsberg, Germany, 58285

Status
Completed
 
Locations

Investigative Site

Krumbach, Germany, 86381

Status
Completed
 
Locations

Investigative Site

Kalbe, Germany, 39624

Status
Completed
 
Locations

Investigative Site

Torino, Italy, 10127

Status
Completed
 
Locations

Investigative Site

Brescia, Italy, 25123

Status
Completed
 
Locations

Investigative Site

Kiev, Ukraine, 04210

Status
Completed
 
Locations

Investigative Site

Chernivtsi, Ukraine, 58017

Status
Completed
 
Locations

Investigative Site

Münster, Germany, 48129

Status
Completed
 
Locations

Investigative Site

Aachen, Germany, 52074

Status
Completed
 
Locations

Investigative Site

Nuernberg, Germany, 90419

Status
Completed
 
Locations

Investigative Site

Giessen, Germany, 35392

Status
Completed
 
Locations

Investigative Site

Leipzig, Germany, 04103

Status
Completed
 
Locations

Investigative Site

Mühlheim, Germany, 63165

Status
Completed
 
Locations

Investigative Site

Marienberg, Germany, 09496

Status
Completed
 
Locations

Investigative Site

München, Germany, 81241

Status
Completed
 
Locations

Investigative Site

Cagliari, Italy, 09124

Status
Completed
 
Locations

Investigative Site

Roma, Italy, 00165

Status
Completed
 
Locations

Investigative Site

Napoli, Italy, 80138

Status
Completed
 
Locations

Investigative Site

Kiev, Ukraine, 01030

Status
Completed
 
Locations

Investigative Site

Kiev, Ukraine, 04050

Status
Completed
 
Locations

Investigative Site

Vinnitsa, Ukraine, 21000

Status
Completed
 
Locations

Investigative Site

Kiev, Ukraine, 04107

Status
Completed
 

Trial Design